Molekule Consulting, Inc. To Sponsor & Exhibit At The 2015 Pharma Ci Europe Conference & Exhibition

Top Quote Molekule Consulting, Inc. is pleased to announce it will be sponsoring and exhibiting at the 2015 Pharma CI Europe Conference & Exhibition, Amsterdam, NL - February 24-25, 2015. End Quote

    "We continue to grow our footprint globally and putting the Molekule Consulting brand at the forefront of Pharma CI Europe is something we believe is critical to educating European biopharmaceutical CI consumers of the differentiation and benefits of the Molekule brand," stated David Alderman, Founder and President, Molekule Consulting.

    The Pharma CI Europe Conference & Expo is the world's premiere gathering of biopharmaceutical competitive intelligence executives. Molekule Consulting stands out among its peers as a specialist biopharmaceutical competitive intelligence consultancy offering eighteen (18) core service offerings across twenty-one (21) key therapy areas served. "We invite you to join us at the Molekule both on the exhibition floor; meet our team, learn more about Molekule as a firm and understand the reasons why our client partners continue claim Molekule as their primary CI vendor," said Alderman.

    "We are excited about the website refresh and launch. The robust information provides to clients and prospective accounts enables their better understanding Molekule Consulting's proprietary, methodical and diligent path to primary competitive intelligence collection, analysis and actionability," said David Alderman, Molekule Consulting Founder and President. "We believe that the refreshed Molekule web presence enables our visitors to have a very informed experience as we continue to grow and increase our market presence, globally," said Alderman.

    Mr. Alderman, President of Molekule Consulting, will be delivering a subject matter expert ("SME") speech entitled, "At the Intersection of Tactical Implementation and Corporate, Franchise and Brand Strategy - Competitive Intelligence - A Central Driver of Biopharmaceutical Marketing and Strategic Thinking," Wednesday, 25 February 2015 - 12:30-13:05. "I think the most critical take-away from my talk will be that via informed, pragmatic and actionable competitive intelligence research, biopharmaceutical executives gain granular insights enabling them to "win" in the increasingly competitive and dynamic biopharmaceutical landscape," added Alderman.

    "Molekule's high quality primary competitive insights and intelligence inform our biopharmaceutical clients - representing the full gamut of MNC ethical pharma to smaller start-ups - the granular data points that matter. Taking into account the clear, concise and leveragable strategic and tactical intelligence that Molekule provides as a firm in support of our client partners, we guide pharma to make informed decisions via aligned intelligence and focused results," asserted Mr. Alderman.

    The Molekule Consulting team looks forward to meeting you at Pharma CI Europe. If you have any questions and/or wish to learn more about our firm, please visit our website:

    About Molekule Consulting Inc.
    Molekule Consulting Inc. ("Molekule") is a recognized global leader in the development and refinement of primary competitive insights and intelligence for the biopharmaceutical and life sciences industries. Molekule aligns intelligence outcomes, focuses results and enables our client partners the ability to "win" in the highly dynamic and competitive biopharmaceutical space. Molekule Consulting remains a trusted partner of biopharmaceutical players today and tomorrow.

    David Alderman +1 305-504-3030
    dalderman ( @ ) molekuleconsulting dot com

  • FB Icon Twitter Icon In-Icon
Contact Information